Nakano T - Search Results

1

Effects of Comb Tooth Cap Medicinal Mushroom, Hericium ramosum (Higher Basidiomycetes) Mycelia on DPPH Radical Scavenging Activity and Nerve Growth Factor Synthesis.

Suruga K, Kadokura K, Sekino Y, Nakano T, Matsuo K, Irie K, Mishima K, Yoneyama M, Komatsu Y. Suruga K, et al. Among authors: nakano t. Int J Med Mushrooms. 2015;17(4):331-8. doi: 10.1615/intjmedmushrooms.v17.i4.20. Int J Med Mushrooms. 2015. PMID: 25954959

2

Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism.

Hayakawa K, Irie K, Sano K, Watanabe T, Higuchi S, Enoki M, Nakano T, Harada K, Ishikane S, Ikeda T, Fujioka M, Orito K, Iwasaki K, Mishima K, Fujiwara M. Hayakawa K, et al. Among authors: nakano t. Biol Pharm Bull. 2009 Sep;32(9):1538-44. doi: 10.1248/bpb.32.1538. Biol Pharm Bull. 2009. PMID: 19721229 Free article.

3

ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Fujioka M, Hayakawa K, Mishima K, Kunizawa A, Irie K, Higuchi S, Nakano T, Muroi C, Fukushima H, Sugimoto M, Banno F, Kokame K, Miyata T, Fujiwara M, Okuchi K, Nishio K. Fujioka M, et al. Among authors: nakano t. Blood. 2010 Feb 25;115(8):1650-3. doi: 10.1182/blood-2009-06-230110. Epub 2009 Nov 13. Blood. 2010. PMID: 19965676 Free article.

4

Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice.

Hayakawa K, Nakano T, Irie K, Higuchi S, Fujioka M, Orito K, Iwasaki K, Jin G, Lo EH, Mishima K, Fujiwara M. Hayakawa K, et al. Among authors: nakano t. J Cereb Blood Flow Metab. 2010 Apr;30(4):871-82. doi: 10.1038/jcbfm.2009.257. Epub 2009 Dec 9. J Cereb Blood Flow Metab. 2010. PMID: 19997116 Free PMC article.

5

Reducing acyl migration during purification of 2-arachidonoylglycerol from biological samples before gas chromatography mass spectrometry analysis.

Higuchi S, Irie K, Nakano T, Sakamoto Y, Akitake Y, Araki M, Ohji M, Furuta R, Katsuki M, Yamaguchi R, Matsuyama K, Mishima K, Mishima K, Iwasaki K, Fujiwara M. Higuchi S, et al. Among authors: nakano t. Anal Sci. 2010;26(11):1199-202. doi: 10.2116/analsci.26.1199. Anal Sci. 2010. PMID: 21079352 Free article.

6

ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.

Fujioka M, Nakano T, Hayakawa K, Irie K, Akitake Y, Sakamoto Y, Mishima K, Muroi C, Yonekawa Y, Banno F, Kokame K, Miyata T, Nishio K, Okuchi K, Iwasaki K, Fujiwara M, Siesjö BK. Fujioka M, et al. Among authors: nakano t. Neurol Sci. 2012 Oct;33(5):1107-15. doi: 10.1007/s10072-011-0913-9. Epub 2012 Jan 3. Neurol Sci. 2012. PMID: 22212812 Free article.

7

Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage.

Muroi C, Fujioka M, Mishima K, Irie K, Fujimura Y, Nakano T, Fandino J, Keller E, Iwasaki K, Fujiwara M. Muroi C, et al. Among authors: nakano t. J Thromb Haemost. 2014 Apr;12(4):505-14. doi: 10.1111/jth.12511. J Thromb Haemost. 2014. PMID: 24476338 Free article.

8

[Necessity of personalized initial loading dose calculation of teicoplanin by clinical pharmacist-examination of the utility of using systemic inflammatory response syndrome score-].

Nakano T, Nakamura Y, Togawa A, Takata T, Ishikura H, Mishima K, Futagami K. Nakano T, et al. Yakugaku Zasshi. 2014;134(12):1367-73. doi: 10.1248/yakushi.14-00185. Yakugaku Zasshi. 2014. PMID: 25452245 Free article. Japanese.

9

Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.

Nakano T, Irie K, Hayakawa K, Sano K, Nakamura Y, Tanaka M, Yamashita Y, Satho T, Fujioka M, Muroi C, Matsuo K, Ishikura H, Futagami K, Mishima K. Nakano T, et al. Brain Res. 2015 Oct 22;1624:330-335. doi: 10.1016/j.brainres.2015.07.027. Epub 2015 Aug 5. Brain Res. 2015. PMID: 26254727

10

Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.

Nakamura Y, Nakano T, Irie K, Sano K, Tanaka J, Yamashita Y, Satho T, Matsuo K, Fujioka M, Ishikura H, Mishima K. Nakamura Y, et al. Among authors: nakano t. J Neurol Sci. 2016 Mar 15;362:278-82. doi: 10.1016/j.jns.2016.01.047. Epub 2016 Jan 22. J Neurol Sci. 2016. PMID: 26944163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,577 results

Search Page

Filters